CLINICAL_TRIALS
withdrawal
· 2013-09-06
Clinical Trial Update: Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox. [NA]
Summary
A trial investigating ciclopirox as a chemopreventive/antineoplastic agent for vulvar cancer was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Vulvar Cancer | NA | Status: WITHDRAWN